小盘
Search documents
江钨装备涨2.02%,成交额1866.52万元,主力资金净流入1.02万元
Xin Lang Cai Jing· 2025-11-25 02:18
Core Viewpoint - Jiangxi Jiangtong Rare and Precious Equipment Co., Ltd. has experienced fluctuations in stock price and significant changes in financial performance, indicating potential investment opportunities and risks in the coal and mining sector [1][2]. Financial Performance - As of September 30, 2025, Jiangtong Equipment reported a revenue of 2.452 billion yuan, a year-on-year decrease of 36.25% [2]. - The net profit attributable to shareholders was -307 million yuan, reflecting a year-on-year decline of 64.90% [2]. - The company has cumulatively distributed 806 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3]. Stock Market Activity - On November 25, the stock price rose by 2.02% to 6.57 yuan per share, with a trading volume of 18.6652 million yuan and a turnover rate of 0.29% [1]. - The stock has increased by 55.69% year-to-date, but has seen declines of 4.78% over the last five trading days, 15.55% over the last 20 days, and 10.98% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" 10 times this year, with the most recent appearance on September 29, where it recorded a net buy of -459.227 million yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 11.59% to 49,700, while the average circulating shares per person decreased by 10.39% to 19,920 shares [2]. - The top ten circulating shareholders include Wan Jia Strategic Development Industry Mixed A, which holds 3.8954 million shares as a new shareholder [3]. Business Overview - Jiangtong Equipment, established on December 30, 1999, and listed on July 2, 2002, primarily engages in the research, production, and sales of magnetic separation equipment [2]. - The company's revenue composition includes coal and coke trading (69.71%), coal revenue (17.93%), and other business segments [2].
曼恩斯特涨2.02%,成交额2026.18万元,主力资金净流入131.56万元
Xin Lang Cai Jing· 2025-11-25 02:13
Core Viewpoint - The stock of Mannester has experienced a decline in price this year, with a notable drop in recent trading days, while the company continues to operate in the high-precision coating equipment sector, primarily focusing on energy systems and coating applications [1][2]. Group 1: Stock Performance - As of November 25, Mannester's stock price increased by 2.02% to 53.65 CNY per share, with a trading volume of 20.26 million CNY and a turnover rate of 0.66%, resulting in a total market capitalization of 7.72 billion CNY [1]. - Year-to-date, Mannester's stock price has decreased by 1.00%, with a 10.03% drop over the last five trading days, a 7.36% decline over the last 20 days, and an 18.88% decrease over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Mannester reported a revenue of 947 million CNY, reflecting a year-on-year decrease of 8.05%, and a net profit attributable to shareholders of -35.47 million CNY, which is a significant decline of 155.28% compared to the previous year [2]. Group 3: Shareholder and Institutional Holdings - As of September 30, 2025, Mannester had 22,400 shareholders, a decrease of 9.22% from the previous period, with an average of 2,588 circulating shares per shareholder, which is an increase of 10.16% [2]. - The company has distributed a total of 89.81 million CNY in dividends since its A-share listing [3]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third largest with 1.25 million shares, an increase of 858,400 shares from the previous period [3].
深圳新星跌2.01%,成交额1.60亿元,主力资金净流入393.83万元
Xin Lang Zheng Quan· 2025-11-25 02:08
Company Overview - Shenzhen New Star Light Alloy Materials Co., Ltd. is located in Bao'an District, Shenzhen, Guangdong Province, and was established on July 23, 1992. The company was listed on August 7, 2017. Its main business involves the research, production, and sales of aluminum grain refiners [2] - The revenue composition of the company includes: aluminum foil raw materials 53.96%, aluminum grain refiners 33.53%, other products 7.92%, lithium hexafluorophosphate 4.19%, and others 0.40% [2] - The company belongs to the non-ferrous metals industry, specifically in the metal new materials sector, and is associated with concepts such as lithium hexafluorophosphate, fluorine chemicals, non-ferrous aluminum, PVDF concepts, and small-cap stocks [2] Financial Performance - For the period from January to September 2025, Shenzhen New Star achieved operating revenue of 2.324 billion yuan, representing a year-on-year growth of 25.54%. The net profit attributable to the parent company was -61.83 million yuan, showing a year-on-year increase of 37.02% [2] - Since its A-share listing, the company has distributed a total of 42 million yuan in dividends, with no dividends distributed in the last three years [3] Stock Market Activity - As of November 25, Shenzhen New Star's stock price decreased by 2.01%, trading at 31.20 yuan per share, with a total market capitalization of 6.586 billion yuan [1] - The stock has seen a year-to-date increase of 102.47%, with a recent decline of 5.77% over the last five trading days, and increases of 23.91% over the last 20 days and 78.90% over the last 60 days [1] - The company has appeared on the daily trading leaderboard three times this year, with the most recent appearance on November 10, where it recorded a net purchase of 121 million yuan [1]
青山纸业涨2.06%,成交额8643.46万元,主力资金净流入1270.96万元
Xin Lang Cai Jing· 2025-11-25 02:07
Core Viewpoint - Qing Shan Paper Industry's stock has shown significant volatility, with a year-to-date increase of 35.79% but a recent decline of 12.63% over the past five trading days [1] Financial Performance - For the period from January to September 2025, Qing Shan Paper Industry reported a revenue of 1.768 billion yuan, a year-on-year decrease of 11.87% [2] - The net profit attributable to the parent company for the same period was 64.99 million yuan, down 25.07% year-on-year [2] Stock Market Activity - As of November 25, the stock price was 3.46 yuan per share, with a market capitalization of 7.753 billion yuan [1] - The stock has been on the "龙虎榜" (a trading list for stocks with significant trading activity) 14 times this year, with the latest appearance on October 20, where it saw a net buy of 51.29 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 207,900, a rise of 113.93% from the previous period [2] - The average number of circulating shares per shareholder decreased by 53.26% to 10,640 shares [2] Dividend Distribution - Since its A-share listing, Qing Shan Paper Industry has distributed a total of 321 million yuan in dividends, with 175 million yuan distributed over the last three years [3] Business Segments - The company's main business segments include pulp industry (67.47% of revenue), pharmaceutical industry (15.32%), paper product processing (11.45%), and others [2]
润达医疗涨2.11%,成交额7087.17万元,主力资金净流入242.94万元
Xin Lang Cai Jing· 2025-11-25 02:04
Core Viewpoint - RunDa Medical's stock has shown mixed performance in recent trading sessions, with a slight increase in price but a significant decline in revenue and profit year-over-year [1][2]. Financial Performance - As of September 30, 2025, RunDa Medical reported a revenue of 5.268 billion yuan, representing a year-over-year decrease of 14.70% [2]. - The company experienced a net profit loss of 163 million yuan, a substantial decline of 422.64% compared to the previous year [2]. Stock Performance - On November 25, 2025, RunDa Medical's stock price increased by 2.11%, reaching 16.45 yuan per share, with a total market capitalization of 9.93 billion yuan [1]. - Year-to-date, the stock has risen by 3.46%, with a 3.01% increase over the last five trading days and a 6.61% increase over the last 20 days, while it has decreased by 12.96% over the last 60 days [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 64,800, a reduction of 1.05% from the previous period [2]. - The average number of circulating shares per shareholder increased by 1.06% to 9,317 shares [2]. Dividend Information - RunDa Medical has distributed a total of 373 million yuan in dividends since its A-share listing, with 165 million yuan distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders, the Southern CSI 1000 ETF holds 4.4119 million shares, a decrease of 48,700 shares from the previous period [3]. - Hong Kong Central Clearing Limited is a new entrant among the top ten shareholders, holding 4.1516 million shares [3].
西点药业涨2.05%,成交额544.71万元
Xin Lang Zheng Quan· 2025-11-25 01:53
Core Viewpoint - Xidian Pharmaceutical's stock price has shown fluctuations, with a year-to-date increase of 18.89% but a recent decline in the last five trading days by 4.10% [1] Company Overview - Xidian Pharmaceutical, established on March 21, 1990, and listed on February 23, 2022, is located in Jilin Province and specializes in the research, production, and sales of chemical pharmaceutical raw materials and formulations [1] - The company's main revenue sources are: Risperidone orally disintegrating tablets (54.15%) and Compound Ferrous Sulfate Folic Acid Tablets (45.13%), with other products contributing 0.72% [1] Financial Performance - For the period from January to September 2025, Xidian Pharmaceutical reported operating revenue of 189 million yuan, a year-on-year decrease of 1.89%, and a net profit attributable to shareholders of 33.14 million yuan, down 2.70% year-on-year [1] - As of September 30, the number of shareholders decreased by 2.91% to 7,863, while the average circulating shares per person increased by 2.97% to 7,426 shares [1] Market Activity - On November 25, Xidian Pharmaceutical's stock rose by 2.05% to 30.90 yuan per share, with a trading volume of 5.4471 million yuan and a turnover rate of 0.30%, resulting in a total market capitalization of 2.364 billion yuan [1] - The stock has experienced a decline of 1.65% over the past 20 days and 5.65% over the past 60 days [1] Dividend Information - Since its A-share listing, Xidian Pharmaceutical has distributed a total of 63.34 million yuan in dividends, with 52.83 million yuan distributed over the past three years [2]
九牧王跌2.01%,成交额3.44亿元,主力资金净流出5658.61万元
Xin Lang Cai Jing· 2025-11-25 01:53
Core Viewpoint - Jiumuwang's stock price has experienced significant fluctuations, with an 80.15% increase year-to-date, but a recent decline of 4.01% over the last five trading days [1] Group 1: Stock Performance - As of November 25, Jiumuwang's stock price was 14.61 CNY per share, with a market capitalization of 8.395 billion CNY [1] - The stock has seen a net outflow of 56.5861 million CNY in principal funds, with large orders showing a buy of 63.1121 million CNY and a sell of 77.1219 million CNY [1] - The stock has appeared on the trading leaderboard six times this year, with the latest appearance on November 24, showing a net buy of 20.6295 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, Jiumuwang reported a revenue of 2.13 billion CNY, a year-on-year decrease of 6.02%, while net profit attributable to shareholders increased by 129.63% to 310 million CNY [2] - The company has distributed a total of 5.09 billion CNY in dividends since its A-share listing, with 402 million CNY distributed in the last three years [3] Group 3: Shareholder Information - As of September 30, 2025, the number of Jiumuwang's shareholders was 14,200, a decrease of 6.01% from the previous period [2] - The average circulating shares per person increased by 6.40% to 40,410 shares [2] - Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3]
百川股份涨2.03%,成交额1.28亿元,主力资金净流入178.64万元
Xin Lang Cai Jing· 2025-11-25 01:52
Group 1 - The core viewpoint of the news is that Baichuan Co., Ltd. has shown a positive stock performance with a year-to-date increase of 8.50% and a recent rise of 2.03% on November 25, reaching a stock price of 8.04 yuan per share [1] - As of September 30, 2025, Baichuan Co., Ltd. reported a revenue of 4.277 billion yuan, reflecting a year-on-year growth of 9.40%, while the net profit attributable to shareholders decreased by 95.32% to 4.807 million yuan [2] - The company operates in three main business segments: fine chemicals (75.51% of revenue), new materials (18.65%), and new energy (5.84%) [1] Group 2 - The company has a total market capitalization of 4.778 billion yuan and a trading volume of 128 million yuan on November 25, with a turnover rate of 3.09% [1] - The number of shareholders as of September 30, 2025, is 78,200, which is a decrease of 3.01% from the previous period, while the average circulating shares per person increased by 3.10% to 6,638 shares [2] - Baichuan Co., Ltd. has distributed a total of 550 million yuan in dividends since its A-share listing, with 65.3136 million yuan distributed over the past three years [2]
金通灵涨2.05%,成交额9409.45万元,主力资金净流出95.53万元
Xin Lang Zheng Quan· 2025-11-24 06:34
Group 1 - The core viewpoint of the news is that Jintongling's stock has shown significant volatility, with a year-to-date increase of 45.37% but a recent decline of 12.35% over the last five trading days [2] - As of November 24, Jintongling's stock price was 2.98 CNY per share, with a market capitalization of 4.438 billion CNY and a trading volume of 94.0945 million CNY [1] - The company has experienced a net outflow of 955,300 CNY in principal funds, with large orders accounting for 23.67% of total buying and 24.69% of total selling [1] Group 2 - Jintongling's main business includes the research, manufacturing, and application of high-end fluid machinery products, with revenue composition as follows: blowers 38.82%, system integration projects 16.34%, boiler sales 13.12%, compressors 12.00%, and others [2] - As of September 30, the number of shareholders decreased by 6.29% to 42,600, while the average circulating shares per person increased by 6.71% to 34,613 shares [3] - For the period from January to September 2025, Jintongling reported a revenue of 548 million CNY, a year-on-year decrease of 47.95%, and a net profit attributable to shareholders of -26.8 million CNY, a decrease of 91.08% [3] Group 3 - Jintongling has cumulatively distributed 109 million CNY in dividends since its A-share listing, with no dividends distributed in the last three years [4]
普莱得涨2.17%,成交额1538.40万元,主力资金净流入32.56万元
Xin Lang Cai Jing· 2025-11-24 06:31
Core Viewpoint - The stock of Pulaide has shown a mixed performance, with a year-to-date increase of 31.13% but a recent decline over the past five and twenty trading days, indicating potential volatility in the market [1]. Group 1: Stock Performance - As of November 24, Pulaide's stock price increased by 2.17% to 27.36 CNY per share, with a trading volume of 15.384 million CNY and a turnover rate of 1.78%, resulting in a total market capitalization of 2.686 billion CNY [1]. - The stock has experienced a decline of 5.75% over the last five trading days and 5.98% over the last twenty trading days, while showing a modest increase of 3.01% over the last sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Pulaide achieved a revenue of 697 million CNY, reflecting a year-on-year growth of 7.74%, and a net profit attributable to shareholders of 61.505 million CNY, which is an increase of 11.01% compared to the previous year [1]. - Since its A-share listing, Pulaide has distributed a total of 59.2672 million CNY in dividends [2]. Group 3: Company Overview - Pulaide Electric Co., Ltd. is located in Jinhua City, Zhejiang Province, and was established on November 1, 2005. The company specializes in the research, design, production, and sales of power tools [1]. - The main revenue sources for Pulaide are power tool assemblies (94.85%), power tool accessories (3.66%), and other supplementary products (1.49%) [1]. - As of September 30, 2025, the number of shareholders for Pulaide was 8,602, a decrease of 2.42% from the previous period, with an average of 3,706 circulating shares per person, which is an increase of 2.48% [1].